The VPS35 Gene PARK17 Parkinson Genetic Test is a specialized diagnostic examination designed to detect mutations in the VPS35 gene, which have been associated with an increased risk of developing Parkinson's disease. This test is particularly crucial for individuals who have a family history of Parkinson's or exhibit early symptoms of the disease, as it can provide valuable insights into their genetic predisposition to this neurodegenerative disorder. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab, and analyzing it for specific mutations in the VPS35 gene linked to Parkinson's disease. The cost of the VPS35 Gene PARK17 Parkinson Genetic Test is 4400 AED, reflecting the sophisticated technology and expert analysis involved in identifying these genetic markers. By opting for this test, individuals can gain early awareness of their risk, enabling them to make informed decisions about their health and potentially access early interventions or personalized management plans to mitigate the impact of Parkinson's disease.
The DNAJC6 gene, associated with PARK19, is linked to a form of juvenile-onset Parkinson's disease, a neurological disorder characterized by movement difficulties, muscle rigidity, and tremors. This particular gene plays a crucial role in the health and function of neurons in the brain. Mutations in DNAJC6 can lead to the early development of Parkinson's disease symptoms, often before the age of 40.
To diagnose this condition and assess the risk in individuals with a family history of juvenile-onset Parkinson's disease, genetic testing is available. DNA Labs UAE offers a comprehensive test targeting the DNAJC6 gene to identify mutations that are associated with PARK19. This test is crucial for early diagnosis and management of the condition, enabling healthcare providers to tailor treatment plans to the individual's genetic profile.
The cost of the DNAJC6 Gene PARK19 Parkinson Juvenile-Onset Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the expenses of the genetic analysis and the provision of a detailed report by the lab's geneticists. The report not only offers insights into the individual's genetic predisposition to developing Parkinson's disease but also provides valuable information for family planning and the possibility of genetic counseling for relatives.
Overall, this genetic test represents a significant step forward in the personalized medicine approach to treating neurological disorders, offering hope and actionable insights to individuals and families affected by juvenile-onset Parkinson's disease.
The PRKN Gene (PARK2) Parkinson Genetic Test is a specialized diagnostic procedure designed to identify mutations in the PARK2 gene, which is closely associated with the development of Parkinson's disease. This test is crucial for individuals who have a family history of Parkinson's disease or exhibit early symptoms, as it can provide vital information regarding their risk of developing the condition.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for specific genetic alterations in the PARK2 gene. These mutations are known to cause the early onset of Parkinson's disease by affecting the function of the protein parkin, which plays a significant role in the degradation of unwanted proteins in brain cells.
The cost of the PRKN Gene (PARK2) Parkinson Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the PARK2 gene. For individuals at risk, this test provides invaluable insights into their genetic predisposition to Parkinson's disease, enabling them to make informed decisions about their health and future.
The SYNJ1 Gene PARK20 Parkinson Genetic Test is a specialized genetic test offered by DNA Labs UAE, designed to identify mutations in the SYNJ1 gene that are associated with Parkinson's disease type 20 (PARK20). This form of Parkinson's disease is rare and typically follows an autosomal recessive pattern of inheritance, meaning that two copies of the mutated gene, one from each parent, are necessary for the disease to manifest.
This test is crucial for individuals who have a family history of Parkinson's disease or exhibit early symptoms of the condition, as it can provide definitive genetic evidence of the presence of the specific mutations linked to PARK20. The outcome of the test can aid in the early diagnosis of the condition, enabling timely intervention and management strategies that can significantly improve the quality of life for affected individuals.
The cost of the SYNJ1 Gene PARK20 Parkinson Genetic Test at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of mutations in the SYNJ1 gene. The results of this test not only offer valuable information for the individual tested but can also provide important genetic insights for their family members, guiding future genetic counseling and testing decisions.
Given the complex nature of genetic testing and the implications of the results, individuals considering this test are advised to undergo genetic counseling before and after testing to fully understand the potential outcomes and their impact on health and family planning decisions.
The DNAJC13 gene, also associated with the PARK21 locus, has been implicated in the genetic landscape of Parkinson's disease, a progressive neurodegenerative disorder characterized by the loss of dopamine-producing neurons in the brain. Mutations in the DNAJC13 gene are linked to an increased risk of developing Parkinson's disease, highlighting its significance in genetic testing for early detection and personalized management of the condition.
The DNAJC13 Gene PARK21 Parkinson Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the DNAJC13 gene that may indicate a predisposition to Parkinson's disease. By analyzing a sample of the patient's DNA, this test can identify specific genetic variants associated with the condition, providing valuable information for individuals with a family history of Parkinson's disease or those exhibiting early symptoms.
The cost of the DNAJC13 Gene PARK21 Parkinson Genetic Test at DNA Labs UAE is 4400 AED. This investment in genetic testing can be pivotal for early intervention strategies, potentially altering the course of the disease through tailored treatment plans and lifestyle adjustments aimed at managing symptoms and improving the quality of life for individuals at risk.
The SNCA Gene PARK4 Parkinson Genetic Test is a specialized diagnostic tool designed to identify mutations in the SNCA gene, which are associated with the development of Parkinson's disease, specifically the PARK4 variant. This genetic test is crucial for individuals with a family history of Parkinson's disease or those who show early symptoms, as it can provide valuable insights into their risk of developing this neurodegenerative disorder.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test involves a detailed analysis of the SNCA gene to detect abnormalities that could lead to Parkinson's disease. The process is straightforward, requiring a simple sample of DNA, usually obtained from a blood draw or cheek swab.
The cost of the SNCA Gene PARK4 Parkinson Genetic Test at DNA Labs UAE is 4400 AED. Although the price may seem high, the test offers potentially invaluable information for individuals and families at risk, enabling early intervention strategies and personalized management plans to mitigate the impact of Parkinson's disease.
The UCHL1 Gene PARK5 Parkinson Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the UCHL1 gene, which have been associated with a rare familial form of Parkinson's disease. This gene plays a crucial role in the pathogenesis of Parkinson's disease by influencing the ubiquitin-proteasome system, crucial for protein degradation and clearance in neural cells. Mutations in the UCHL1 gene can lead to abnormal protein accumulation, contributing to neurodegeneration observed in Parkinson's disease.
The test is priced at 4400 AED and involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory using advanced genetic sequencing techniques. The aim is to detect any genetic alterations in the UCHL1 gene that may indicate an increased risk of developing Parkinson's disease, particularly in individuals with a family history of the condition.
By identifying these genetic markers early, the UCHL1 Gene PARK5 Parkinson Genetic Test can provide crucial information for risk assessment and potential early intervention strategies. It's an important tool in the management and understanding of Parkinson's disease, offering hope for those seeking to understand their genetic predisposition to this challenging neurodegenerative disorder.
The PINK1 Gene PARK6 Parkinson Genetic Test is a specialized diagnostic examination designed to detect mutations in the PTEN-induced kinase 1 (PINK1) gene, which is associated with PARK6, a form of early-onset Parkinson's disease. This genetic test is crucial for individuals with a family history of Parkinson's disease or those who exhibit symptoms at an early age, as it can provide definitive information regarding their genetic predisposition to this form of the condition. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis to identify the specific mutations in the PINK1 gene that are linked to the development of Parkinson's disease. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify and interpret the genetic variations associated with the condition. This test not only aids in the early diagnosis and understanding of the patient's condition but also in the planning of personalized management and treatment strategies, potentially improving the quality of life for those affected by this form of Parkinson's disease.
The "EOMES Gene Neuronal Migration Disorder Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the EOMES gene, which are linked to various neuronal migration disorders. These disorders can affect brain development, leading to a range of neurological symptoms and conditions. The EOMES gene plays a crucial role in the development and migration of neurons during embryonic brain development. Mutations in this gene can disrupt normal brain formation, resulting in developmental delays, intellectual disabilities, and other neurological issues.
This genetic test involves analyzing the patient's DNA to detect any abnormalities in the EOMES gene that may be responsible for such conditions. It is a critical step in diagnosing specific neuronal migration disorders, allowing for a better understanding of the condition and enabling healthcare providers to tailor treatment and management plans more effectively.
The test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing services. The cost of the EOMES Gene Neuronal Migration Disorder Genetic Test is 4400 AED, reflecting the sophisticated technology and expertise required to perform this intricate analysis. By offering this test, DNA Labs UAE provides essential support for individuals and families seeking answers to complex neurological conditions, contributing to improved patient care and outcomes in the field of genetic disorders.
The SPTBN5 gene neuronal migration disorder genetic test is a specialized diagnostic procedure aimed at detecting mutations in the SPTBN5 gene, which have been associated with disorders affecting neuronal migration. Neuronal migration disorders are a group of conditions that occur when nerve cells (neurons) do not move to their correct location in the developing brain during early fetal development. This can lead to a variety of neurological and developmental problems, including intellectual disabilities, epilepsy, and motor disorders.
This test, performed at DNA Labs UAE, uses advanced genetic sequencing technologies to analyze the SPTBN5 gene for any abnormalities that might be linked to these disorders. By identifying specific genetic mutations, healthcare providers can make accurate diagnoses, better understand the condition's prognosis, and in some cases, offer targeted treatments or interventions that can improve patient outcomes.
The cost of the SPTBN5 gene neuronal migration disorder genetic test at DNA Labs UAE is 4400 AED. This price reflects the intricate process of genetic analysis and the expertise required to interpret the results accurately. For families and individuals facing the challenges associated with neuronal migration disorders, this test represents a crucial step towards obtaining a clear diagnosis and the possibility of personalized care planning.
